• BML-277: Potent Chk2 Inhibitor for DNA Damage Response Re...

  2025-10-21

  BML-277 stands out as a potent and selective Chk2 kinase inhibitor, enabling precise dissection of DNA damage checkpoint pathways and radioprotection mechanisms in T-cells. Its ATP-competitive inhibition, high selectivity, and unique role in the nuclear cGAS-TRIM41 axis position it as a pivotal tool for advanced cancer research and genome stability studies.

• Epoxomicin and Proteasome Beta-5 Subunit Inhibition: Unve...

  2025-10-20

  Discover how Epoxomicin, a selective 20S proteasome inhibitor, is transforming ubiquitin-proteasome pathway research by enabling unprecedented precision in dissecting proteasome beta-5 subunit function, ER stress adaptation, and cellular quality control. Explore advanced applications and comparative insights beyond conventional reviews.

• Protoporphyrin IX: Molecular Nexus of Heme Synthesis and ...

  2025-10-19

  Explore the pivotal role of Protoporphyrin IX in heme biosynthesis, iron chelation, and its emerging significance in ferroptosis and photodynamic therapy. This article delivers advanced mechanistic insights and translational perspectives beyond standard guides.

• Epoxomicin: Illuminating Proteasome Regulation in Inflamm...

  2025-10-18

  Explore how Epoxomicin, a selective 20S proteasome inhibitor, uniquely advances research into inflammation and viral pathogenesis via targeted modulation of protein degradation. This article provides a deeper mechanistic and translational analysis beyond standard assays.

94 records 7/7 page Previous First page 上5页 67